Medix Infusion, a Dallas, TX-based company that creates access to infusion therapy for patients in rural, suburban and other underserved markets, raised $35M in Series B funding.
The round was led by Echo Health Ventures, with participation from Pittco Direct Investments II, and Noro-Moseley Partners. Medix Infusion simultaneously entered into a debt facility with Live Oak Bank.
Led by CEO Gus de Avillez, Medix Infusion is a multi-state health care company focused on providing infusion and injectable therapy to chronically and acutely ill patients at home or in one of its many ambulatory infusion centers. Medix focuses on rural, suburban, and other under-served markets now operating more than 30 locations across five states along with its home infusion pharmacy operations.
With the acquisition of infusion assets in Arizona, the company continues to emerge as one of the leading infusion platforms in the U.S. The acquisition expands the geographic footprint into its fifth state with additional operations in Texas, Oregon, Kansas and Missouri.
